Shijiazhuang Yiling Pharmaceutical Co., Ltd.
002603
Classement en actions
#4179
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and... Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
Prix de l'action
$2.29
Capitalisation boursière
$3.83B
Changement (1 jour)
3.06%
Changement (1 an)
-6.38%
Pays
CN
Échange Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
Catégorie
Healthcare
Bénéfices pour Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
Bénéfices en Jun 2026 TTM : $246.26M
Selon les derniers rapports financiers de Shijiazhuang Yiling Pharmaceutical Co., Ltd., les bénéfices actuels de l'entreprise sont de $246.26M. En 2023, l'entreprise a réalisé un bénéfice de $237.93M, une diminution par rapport à celui de 2022 qui était de $403.11M. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Shijiazhuang Yiling Pharmaceutical Co., Ltd. de 2008 à 2026
Bénéfices à la fin de chaque année
| Année | Bénéfices | Changez |
|---|---|---|
| 2026 (TTM) | $246.26M | -324.63% |
| 2024 | $-109.63M | -146.08% |
| 2023 | $237.93M | -40.98% |
| 2022 | $403.11M | 64.90% |
| 2021 | $244.45M | 12.26% |
| 2020 | $217.75M | 114.19% |
| 2019 | $101.66M | -0.25% |
| 2018 | $101.91M | 3.87% |
| 2017 | $98.11M | 8.63% |
| 2016 | $90.32M | 17.44% |
| 2015 | $76.90M | 16.02% |
| 2014 | $66.28M | 38.96% |
| 2013 | $47.70M | 37.56% |
| 2012 | $34.68M | -58.95% |
| 2011 | $84.47M | 51.19% |
| 2010 | $55.87M | 7.65% |
| 2009 | $51.90M | 145.52% |
| 2008 | $21.14M | 0.00% |
Bénéfices des entreprises similaires ou concurrentes
| Entreprise | Bénéfices | Différence de bénéfices | Pays |
|---|---|---|---|
| $1.35B | 448.16% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| $26.37M | -89.29% |
US
|
|
| - | - |
IT
|
